Literature DB >> 31406951

Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Zdravka Daneva1, Victor E Laubach2, Swapnil K Sonkusare1,3.   

Abstract

Dysregulated redox signaling in pulmonary vasculature is central to the development of pulmonary arterial hypertension (PAH) and lung injury. Modulators of reactive oxygen species (ROS) production and downstream signaling targets are critical for mediating the physiological or pathological effects of ROS. Understanding the complex interactions between the modulators and signaling targets of ROS is essential for developing novel strategies to prevent or attenuate lung pathologies. In this review, we discuss recent studies on the modulators and targets of ROS in pulmonary endothelial and smooth muscle cells, their cellular effects, and the disease conditions associated with dysregulated redox signaling.

Entities:  

Keywords:  Redox signaling; endothelial cell; lung injury; pulmonary hypertension; smooth muscle cell

Year:  2019        PMID: 31406951      PMCID: PMC6690609          DOI: 10.1016/j.cophys.2019.04.026

Source DB:  PubMed          Journal:  Curr Opin Physiol        ISSN: 2468-8673


  50 in total

1.  Cyclophilin A is a secreted growth factor induced by oxidative stress.

Authors:  Z G Jin; M G Melaragno; D F Liao; C Yan; J Haendeler; Y A Suh; J D Lambeth; B C Berk
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

2.  Oxidative stress modulates PPAR gamma in vascular endothelial cells.

Authors:  Carmelo Blanquicett; Bum-Yong Kang; Jeffrey D Ritzenthaler; Dean P Jones; C Michael Hart
Journal:  Free Radic Biol Med       Date:  2010-03-17       Impact factor: 7.376

3.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

4.  NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation.

Authors:  Siobhan M Craige; Kai Chen; Yongmei Pei; Chunying Li; Xiaoyun Huang; Christine Chen; Rei Shibata; Kaori Sato; Kenneth Walsh; John F Keaney
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

5.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

Review 6.  Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.

Authors:  Mona Sedeek; Richard L Hébert; Chris R Kennedy; Kevin D Burns; Rhian M Touyz
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

Review 7.  Antioxidant responses to oxidant-mediated lung diseases.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

8.  Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

Authors:  Rachel E Nisbet; Jennifer M Bland; Dean J Kleinhenz; Patrick O Mitchell; Erik R Walp; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

9.  Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.

Authors:  Peter Dorfmüller; Marie-Camille Chaumais; Maria Giannakouli; Ingrid Durand-Gasselin; Nicolas Raymond; Elie Fadel; Olaf Mercier; Frédéric Charlotte; David Montani; Gérald Simonneau; Marc Humbert; Frédéric Perros
Journal:  Respir Res       Date:  2011-09-09

10.  Regulation of ROS signal transduction by NADPH oxidase 4 localization.

Authors:  Kai Chen; Michael T Kirber; Hui Xiao; Yu Yang; John F Keaney
Journal:  J Cell Biol       Date:  2008-06-23       Impact factor: 10.539

View more
  3 in total

1.  A simple and accurate HFCF-UF method for the analysis of homocysteine, cysteine, cysteinyl-glycine, and glutathione in human blood.

Authors:  Wei-Chong Dong; Jia-Liang Guo; Meng-Qiang Zhao; Xi-Kun Wu; Yi-Xuan Cui; Jing-Ying Feng; Chen-Xiao Zhang; Ye Jiang; Zhi-Qing Zhang
Journal:  Anal Bioanal Chem       Date:  2021-08-18       Impact factor: 4.142

2.  Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension.

Authors:  Zdravka Daneva; Corina Marziano; Matteo Ottolini; Yen-Lin Chen; Thomas M Baker; Maniselvan Kuppusamy; Aimee Zhang; Huy Q Ta; Claire E Reagan; Andrew D Mihalek; Ramesh B Kasetti; Yuanjun Shen; Brant E Isakson; Richard D Minshall; Gulab S Zode; Elena A Goncharova; Victor E Laubach; Swapnil K Sonkusare
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

3.  Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway.

Authors:  Yaolu Zhu; Yabin Sun; Shichang Zhang; Chuyuan Li; Yiwei Zhao; Boxin Zhao; Guofeng Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.